Genomic Approaches for Disease Diagnosis and Prognosis
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Genetic Diagnosis".
Deadline for manuscript submissions: 15 December 2024 | Viewed by 301
Special Issue Editor
Interests: lncRNA-mediated transcriptional regulation; RNA–chromatin interactions; chromatin architecture; transcriptional and epigenetic regulation in cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Over the last two decades, next generation sequencing (NGS) facilitated the transition of biomedical research into the post-genomic era. Today international consortia, including but not limited to The Cancer Genome Atlas (TCGA), the International Cancer Genome Consortium (ICGC) and the Genotype-Tissue Expression project (gTEX), combine molecular insights (e.g., DNA sequence and structure and/or RNA or protein expression) with clinical manifestations, thereby promoting the development of novel diagnostic and prognostic biomarkers or therapeutic targets.
The same efforts highlight the extensive cellular and molecular heterogeneity that governs complex diseases such as cancer. The development of state-of the art genomic approaches, including single cell sequencing and more recently spatial transcriptomics, is already transforming cellular or spatially organized molecular operation to diagnostic and prognostic opportunity, thus paving the way towards personalized medicine.
This Special Issue welcomes articles that emphasize on the role of genomic approaches and/or methodologies in the form of bulk, single cell or spatial sequencing, as novel clinomics strategies designed to convert genomic function into diagnostic, prognostic and therapeutic action against complex human diseases.
Dr. Antonis Giakountis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
